*Department of Ophthalmology, New York University Langone Health, New York, New York
†Department of Otolaryngology, Johns Hopkins, Baltimore, Maryland
‡Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland
§Department of Ophthalmology, University of Missouri, Columbia, Missouri
∥Department of Ophthalmology, Tufts University Medical Center, Boston, Massachusetts
¶Ophthalmic Plastic and Reconstructive Surgery, Department of Ophthalmology, Columbia University Irving Medical Center, New York, New York
#Oculofacial Plastic and Orbital Surgery, Indianapolis, Indiana
**Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, U.S.A.
Accepted for publication March 26, 2021.
The Departments of Ophthalmology at Columbia University Irving Medical Center and NYU Langone Health are supported by an unrestricted grant from Research to Prevent Blindness.
Irina Belinsky: Participated in a Thyroid Eye Disease Virtual Advisory Board, 7/2020, Horizon Therapeutics; Nicholas Mahoney: Participated in a Thyroid Eye Disease Virtual Advisory Board, 6/2020, Horizon Therapeutics; Michael K. Yoon: Participated in a Thyroid Eye Disease Advisory Board, 6/2019, Horizon Therapeutics.
Address correspondence and reprint requests to Lora R. Dagi Glass, M.D., Ophthalmic Plastic and Reconstructive Surgery, Department of Ophthalmology, Columbia University Irving Medical Center, 635 W. 165th St, PO Box 77, New York, NY 10033. E-mail: [email protected]
